Saccadic movement effects on intraocular drug delivery for a wet-AMD clinical case

How to Cite

Ferroni M, Cereda M, Boschetti F. Saccadic movement effects on intraocular drug delivery for a wet-AMD clinical case. MAIO [Internet]. 2018 Jun. 18 [cited 2024 Apr. 14];2(2):86-91. Available from:

Copyright notice

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication, with the work twelve (12) months after publication simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal.

  2. After 12 months from the date of publication, authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.


age-related macular degeneration (AMD); computational fluid-dynamics; saccade; vitreous drug delivery


Nowadays, intravitreal injections are the gold standard for the treatment of age-related macular degeneration (AMD). The prediction of the transport mechanism for the injected anti vascular endothelial growth factor (anti-VEGF) is needed in order to understand its distribution and consumption after each injection. Thus, this study aims at implementing a full model of vitreous drug delivery. The main novelty of this work is the coupling between an experimental evaluation of the scleral permeability and a numerical analysis of the saccadic dependency of the transport phenomena.


Stay MS, Xu J, Randolph TW, Barocas VH. Computer simulation of convective and diffusive transport of controlled-release drugs in the vitreous humor. Pharm Res. 2003;20(1):96-102. Available from:

Modareszadeh A, Abouali O, Ahmadi GG. Saccade movements effect on the intravitreal drug delivery in vitreous substitutes: a numerical study. Biomech Model Mechanobiol. 2013;12(2):281-290.doi:10.1007/s10237-012-0398-3

Xu J, Heys JJ, Barocas VH, Randolph TW. Permeability and diffusion in vitreous humor: implications for drug delivery. Pharm Res. 2000;17(6):664–669.

Romano MR, Vallejo-Garcia JL, Romano V, Angi M, Vinciguerra P, Costagliola C. Thermodynamics of vitreoretinal surgery. Curr Eye Res. 2013;38(3):371–374. doi:10.3109/02713683.2012.745160

Veurink M, Stella C, Tabatabay C, Pournaras CJ, Gurny R. Association of ranibizumab (Lucentis®) or bevacizumab (Avastin®) with dexamethasone and triamcinolone acetonide: An in vitro stability assessment. Eur J Pharm Biopharm. 2011;78(2):271–277. doi:10.1016/j.ejpb.2010.12.018